Akoya Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Akoya Biosciences

05/05/2022 23:37

* Akoya Biosciences Inc  AKYA.OQ  reported a quarterly
adjusted
loss of 44 cents​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 39 cents per share.
    * Revenue rose 38.3% to $16.89 million from a year ago; 
analysts
expected $14.93 million. 
    * Akoya Biosciences Inc's reported EPS for the quarter was a
loss
of 44 cents​.
    * The mean earnings estimate of analysts had fallen by
about 26%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Akoya Biosciences Inc shares had risen by 0.5% this
quarter and
lost 27.9% so far this year.
    * The company reported a quarterly loss of $16.4 million.
    * Wall Street's median 12-month price target for Akoya
Biosciences
Inc is $19.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 10:37 p.m.  ​All
figures in US dollars unless otherwise stated